Though 42 different pathogenic BRCA1 or BRCA2 variants have been identified in FC cancer families of Quebec, five recurrent pathogenic variants account for 84% of all mutation-positive BC and/or OC families [30]. This evidence concerns the gene BRCA2 and cancer.